278 related articles for article (PubMed ID: 10838684)
21. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
[TBL] [Abstract][Full Text] [Related]
22. Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer.
Gitsch G; Kainz C; Joura E; Fröhlich B; Bieglmayr C; Tatra G
Anticancer Res; 1992; 12(4):1247-9. PubMed ID: 1503417
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK
Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503
[TBL] [Abstract][Full Text] [Related]
24. [A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma].
Ychou M; Khemissa-Akouz F; Kramar A; Senesse P; Grenier J
Bull Cancer; 2001 Oct; 88(10):1023-7. PubMed ID: 11713038
[TBL] [Abstract][Full Text] [Related]
25. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
Wollenberg B; Jan V; Schmit UM; Hofmann K; Stieber P; Fateh-Moghadam A
Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778
[TBL] [Abstract][Full Text] [Related]
26. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix].
Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):625-9. PubMed ID: 2777050
[TBL] [Abstract][Full Text] [Related]
27. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
[TBL] [Abstract][Full Text] [Related]
28. Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?
Chan YM; Ng TY; Ngan HY; Wong LC
Gynecol Oncol; 2002 Jan; 84(1):7-11. PubMed ID: 11748969
[TBL] [Abstract][Full Text] [Related]
29. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma.
Nagler RM; Barak M; Peled M; Ben-Aryeh H; Filatov M; Laufer D
Cancer; 1999 Mar; 85(5):1018-25. PubMed ID: 10091783
[TBL] [Abstract][Full Text] [Related]
30. Clinical value of serum squamous cell carcinoma antigen in the management of sinonasal inverted papilloma.
Yasumatsu R; Nakashima T; Masuda M; Kuratomi Y; Shiratsuchi H; Hirakawa N; Tomita K; Yamamoto T; Komune S
Head Neck; 2005 Jan; 27(1):44-8. PubMed ID: 15459916
[TBL] [Abstract][Full Text] [Related]
31. [Squamous cell carcinoma antigen for monitoring patients with head neoplasm].
Adamiak G; Ligeziński A; Jurkiewicz D; Hermanowski M; Konieczna M
Pol Merkur Lekarski; 1999 Nov; 7(41):221-3. PubMed ID: 10680455
[TBL] [Abstract][Full Text] [Related]
32. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
Gadducci A; Tana R; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
[TBL] [Abstract][Full Text] [Related]
33. Squamous cell carcinoma antigen in oral squamous cell carcinomas.
Nagumo K; Okada N; Takagi M; Yamamoto H; Amagasa T; Fujibayashi T
Bull Tokyo Med Dent Univ; 1990 Jun; 37(1-2):27-34. PubMed ID: 2225283
[TBL] [Abstract][Full Text] [Related]
34. Clinical usage of the squamous cell carcinoma antigen in patients with penile cancer.
Touloupidis S; Zisimopoulos A; Giannakopoulos S; Papatsoris AG; Kalaitzis C; Thanos A
Int J Urol; 2007 Feb; 14(2):174-6. PubMed ID: 17302580
[TBL] [Abstract][Full Text] [Related]
35. Cyfra 21-1 as a serum tumor marker for follow-up of patients with laryngeal and hypopharyngeal squamous cell carcinoma.
Al-Shagahin H; Alkotyfan K; Müller HH; Sesterhenn AM; Werner JA
Anticancer Res; 2009 Aug; 29(8):3421-5. PubMed ID: 19661367
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma.
Nikliński J; Furman M; Laudański J; Kozłowski M
Neoplasma; 1992; 39(5):279-82. PubMed ID: 1331826
[TBL] [Abstract][Full Text] [Related]
37. [Determination of the SCC antigen in the serum of patients with cervical cancer].
Crombach G; Würz H; Bolte A
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
[TBL] [Abstract][Full Text] [Related]
38. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
Hung YC; Shiau YC; Chang WC; Kao CH; Lin CC
Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
[TBL] [Abstract][Full Text] [Related]
39. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
40. [SCC-Ag antigen in serum of patients with primary non-small cell lung carcinoma].
Nikliński J; Furman M; Moniuszko-Jakoniuk J; Laudański J
Pol Tyg Lek; 1993 Jun 21-28; 48(25-26):548-50. PubMed ID: 8008646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
